OPT Stock Discussion

Opthea Limited Description

Opthea Limited operates as a biotechnology company. The Company develops therapies for diabetic macular edema, corneal neovascularization and transplantation, and dry eye disease. Opthea serves patients and healthcare providers in Australia.

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Organ Systems Diabetes Eye Healthcare Providers Ophthalmology Transplantation Eye Diseases Diabetic Retinopathy Macular Edema Diabetic Macular Edema Blindness Cornea Dry Eye Disease Angiology